These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6387831)

  • 1. Biochemical short-term predictive assay: results of correlative trials in comparison to other assays.
    Kaufmann M
    Recent Results Cancer Res; 1984; 94():151-60. PubMed ID: 6387831
    [No Abstract]   [Full Text] [Related]  

  • 2. Predictive tests and infrequent events in cancer chemotherapy.
    Rozencweig M; Staquet M
    Recent Results Cancer Res; 1984; 94():174-83. PubMed ID: 6387832
    [No Abstract]   [Full Text] [Related]  

  • 3. [In vitro evaluation of anticancer drugs and retrospective clinical trials with the human tumor cloning system].
    Inoue K; Ogawa M; Mukaiyama T; Mitsui I; Inagaki J; Horikoshi N
    Nihon Gan Chiryo Gakkai Shi; 1985 Feb; 20(1):59-65. PubMed ID: 3889195
    [No Abstract]   [Full Text] [Related]  

  • 4. Heterogeneity and variability of test results as limiting factors for predictive assays.
    Schlag P; Flentje D
    Recent Results Cancer Res; 1984; 94():191-6. PubMed ID: 6494579
    [No Abstract]   [Full Text] [Related]  

  • 5. Drug evaluation: Bay-59-8862.
    Eckstein JW
    IDrugs; 2004 Jun; 7(6):575-81. PubMed ID: 15197663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of an in vitro screening test of cytotoxic agents in the treatment of advanced malignant disease.
    Wheeler TK; Dendy PP; Dawson A
    Oncology; 1974; 30(5):362-76. PubMed ID: 4462060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Drug sensitivity testing of gynecologic tumors using Volm's test and stem cell assay].
    Eidtmann H; Jonat W; Maass H
    Geburtshilfe Frauenheilkd; 1985 Jul; 45(7):477-81. PubMed ID: 4029587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of high dose chemotherapy in adult solid tumours other than breast cancer.
    Hornedo J; Cortés-Funes H
    Ann Oncol; 1996; 7 Suppl 2():23-30. PubMed ID: 8805946
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment evaluation in active control studies.
    Fleming TR
    Cancer Treat Rep; 1987 Nov; 71(11):1061-5. PubMed ID: 3119201
    [No Abstract]   [Full Text] [Related]  

  • 10. Individualized patient chemotherapy: use of a human tumor colony formation technique.
    Meyskens FL
    Front Radiat Ther Oncol; 1981; 16():55-61. PubMed ID: 7199500
    [No Abstract]   [Full Text] [Related]  

  • 11. [Experience with adriamycin in the treatment of advanced breast and ovarian cancer (author's transl)].
    Kolarić K; Maricić Z ; Krusić J; Nola P
    Lijec Vjesn; 1976 Jun; 98(6):313-16. PubMed ID: 790065
    [No Abstract]   [Full Text] [Related]  

  • 12. In vitro chemosensitivity assay based on the concept of total tumor cell kill.
    Weisenthal LM; Shoemaker RH; Marsden JA; Dill PL; Baker JA; Moran EM
    Recent Results Cancer Res; 1984; 94():161-73. PubMed ID: 6494576
    [No Abstract]   [Full Text] [Related]  

  • 13. Conflicting phase II efficacy data for Doxil.
    Frykman G; Williams G; Pazdur R
    J Clin Oncol; 2001 Jan; 19(2):596-7. PubMed ID: 11208859
    [No Abstract]   [Full Text] [Related]  

  • 14. Development of a nucleotide precursor incorporation assay for testing drug sensitivity of human tumors.
    Sanfilippo O; Daidone MG; Zaffaroni N; Silvestrini R
    Recent Results Cancer Res; 1984; 94():127-39. PubMed ID: 6494574
    [No Abstract]   [Full Text] [Related]  

  • 15. Predicting response of human solid tumors to chemotherapy.
    Tanneberger S; Nissen E
    Cancer Treat Rev; 1983 Dec; 10(4):203-19. PubMed ID: 6362872
    [No Abstract]   [Full Text] [Related]  

  • 16. [1st clinical experiences with isophosphamide. Long-term results of 2 therapeutic approaches].
    Pigatto JC
    Prensa Med Argent; 1971 Oct; 58(32):1618-21. PubMed ID: 4943249
    [No Abstract]   [Full Text] [Related]  

  • 17. Targeting homologous repair deficiency in breast and ovarian cancers: Biological pathways, preclinical and clinical data.
    Chartron E; Theillet C; Guiu S; Jacot W
    Crit Rev Oncol Hematol; 2019 Jan; 133():58-73. PubMed ID: 30661659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adriamycin. A new anticancer drug with significant clinical activity.
    Blum RH; Carter SK
    Ann Intern Med; 1974 Feb; 80(2):249-59. PubMed ID: 4590654
    [No Abstract]   [Full Text] [Related]  

  • 19. Why does chemotherapy stop affecting the cells of ovarian and breast tumors?
    Kalinina EV; Chernov NN
    Future Oncol; 2018 May; 14(12):1137-1140. PubMed ID: 29629566
    [No Abstract]   [Full Text] [Related]  

  • 20. AEZS-108 : a targeted cytotoxic analog of LHRH for the treatment of cancers positive for LHRH receptors.
    Engel J; Emons G; Pinski J; Schally AV
    Expert Opin Investig Drugs; 2012 Jun; 21(6):891-9. PubMed ID: 22577891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.